VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 207 filers reported holding VERACYTE INC in Q1 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48 | +433.3% | 2,146 | +533.0% | 0.00% | – |
| Q2 2023 | $9 | +350.0% | 339 | +208.2% | 0.00% | – |
| Q1 2023 | $2 | -60.0% | 110 | -52.2% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 230 | -71.2% | 0.00% | – |
| Q3 2022 | $13,000 | -18.8% | 800 | -1.0% | 0.00% | – |
| Q2 2022 | $16,000 | +1500.0% | 808 | +2892.6% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 27 | -40.0% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 45 | +36.4% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |